drugset / Trial / NCT02010333

A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation

NCT02010333

Phase 2 Completed 22 enrolled Dr. Reddy's Laboratories Limited
NaSingle-groupOpen-labelTreatment

Summary

The primary purpose of the study is to evaluate safety and tolerability of a single application of Ha44 Gel 0.74% w/w for the treatment of head lice. Secondary purpose is to evaluate PK of Ha44 and benzyl alcohol under conditions of maximal exposure in pediatric population.

Timeline

Start
2013-04
Primary completion
2014-07
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Abametapir Small molecule 0.74 % Topical
Subject Benzyl Alcohol Small molecule Topical